Cell and Gene Therapy CDMO Market Size, Share & Growth Report

Introduction
- Introduction
- Market Scope
  - Market Definition
  - Segments Covered
  - Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
  - Bottom-Up Approach
  - Top-Down Approach
- Market Forecasting
Executive Summary
- Cell and Gene Therapy CDMO Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive In"4">
- Market Overview
  - Market Dynamics
    - Drivers
      - Growing demand for full-service/one-stop-shop CDMOs
      - Advancements in gene editing and delivery technologies
      - Rising demand for cell and gene therapies
      - Growing investment in biopharma R&D
      - Expanding pipeline of cell and gene therapies in clinical trials
    - Restraints
      - Complex regulatory landscape
      - High manufacturing complexity and cost
      - Limited skilled workforce
    - Opportunities
      - Substantial outsourcing in CGT industry
      - Innovative partnerships and collaborations
      - Expansion into emerging markets
      - Development of allogeneic (off-the-shelf) therapies
    - Key Market Trends
      - Increased use of automation and digital manufacturing
      - Focus on viral vector production
      - Integration of end-to-end services
    - Unmet Market Needs
    - Induaks

Global Cell and Gene Therapy CDMO Market Size & Forecast (2023-2030), By Service Type, USD Million
- Introduction
- Clinical Development
- Commercial Manufacturing
Global Cell and Gene Therapy CDMO Market Size & Forecast (2023-2030), By Product Type, USD Million
- Introduction
- Gene Therapy
  - Ex-vivo
  - In-vivo
- Cell Therapy
- Gene-Modified Cell Therapy
  - CAR T-cell therapies
  - CAR-NK cell therapy
  - TCR-T cell therapy
  - Other

Global Cell and Gene Therapy CDMO Market Size & Forecast (2023-2030), By Indication, USD Million
- Introduction
- Oncology
- Neurological Disorders
- Infectious Diseases
- Rare Diseases
- Others
Global Cell and Gene Therapy CDMO Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Cell and Gene Therapy CDMO Market Size & Forecast (2023-2030), By Country, USD Million
  - US
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
  - Canada
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Product Type (USD Million)
    - Market Size & Forecast, By Indication (USD Million)

"9">

Competitive Landscape

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

Note: *Indicative list

**For listed companies

Global Cell and Gene Therapy CDMO Market Size, Share, Growth & Trends Report Segmented by Service Type (Clinical Development, Commercial Manufacturing), Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), Indication & Regional Forecast to 2031